Human cytomegalovirus and transplantation: drug development and regulatory issues

Human cytomegalovirus and transplantation: drug development and regulatory issues

Cytomegalovirus (CMV) infection is highly prevalent worldwide and can cause serious disease among immunocompromised individuals, including persons with HIV and transplant recipients on immunosuppressive therapies. It can also result in congenital cytomegalovirus when women are infected during pregna...

Full description

Bibliographic Details
Main Authors: Megan McIntosh, Benjamin Hauschild, Veronica Miller
Format: Article
Language:English
Published: Elsevier 2016-07-01
Series:Journal of Virus Eradication
Subjects:
Cytomegalovirus
CMV
regulatory science
drug development
Online Access:http://www.sciencedirect.com/science/article/pii/S205566402030457X

Internet

http://www.sciencedirect.com/science/article/pii/S205566402030457X

Similar Items